228 related articles for article (PubMed ID: 24596048)
1. Immune cell quantitation in normal breast tissue lobules with and without lobulitis.
Degnim AC; Brahmbhatt RD; Radisky DC; Hoskin TL; Stallings-Mann M; Laudenschlager M; Mansfield A; Frost MH; Murphy L; Knutson K; Visscher DW
Breast Cancer Res Treat; 2014 Apr; 144(3):539-49. PubMed ID: 24596048
[TBL] [Abstract][Full Text] [Related]
2. The Role of Immune Cells in Breast Tissue and Immunotherapy for the Treatment of Breast Cancer.
Goff SL; Danforth DN
Clin Breast Cancer; 2021 Feb; 21(1):e63-e73. PubMed ID: 32893093
[TBL] [Abstract][Full Text] [Related]
3. Alterations in the Immune Cell Composition in Premalignant Breast Tissue that Precede Breast Cancer Development.
Degnim AC; Hoskin TL; Arshad M; Frost MH; Winham SJ; Brahmbhatt RA; Pena A; Carter JM; Stallings-Mann ML; Murphy LM; Miller EE; Denison LA; Vachon CM; Knutson KL; Radisky DC; Visscher DW
Clin Cancer Res; 2017 Jul; 23(14):3945-3952. PubMed ID: 28126725
[No Abstract] [Full Text] [Related]
4. Lymphocyte subsets contribute to the degree of lobulitis and ductitis in sclerosing lymphocytic lobulitis of the breast.
Chen LY; Tsang JY; Ni YB; Chan SK; Chan KF; Zhang S; Tse GM
J Clin Pathol; 2016 Jun; 69(6):527-32. PubMed ID: 26582743
[TBL] [Abstract][Full Text] [Related]
5. Systemic Inflammation Associates With a Myeloid Inflamed Tumor Microenvironment in Primary Resected Colon Cancer-May Cold Tumors Simply Be Too Hot?
Køstner AH; Nielsen PS; Georgsen JB; Parner ET; Nielsen MB; Kersten C; Steiniche T
Front Immunol; 2021; 12():716342. PubMed ID: 34531864
[TBL] [Abstract][Full Text] [Related]
6. High mammographic density in women is associated with protumor inflammation.
Huo CW; Hill P; Chew G; Neeson PJ; Halse H; Williams ED; Henderson MA; Thompson EW; Britt KL
Breast Cancer Res; 2018 Aug; 20(1):92. PubMed ID: 30092832
[TBL] [Abstract][Full Text] [Related]
7. Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast.
Campbell MJ; Baehner F; O'Meara T; Ojukwu E; Han B; Mukhtar R; Tandon V; Endicott M; Zhu Z; Wong J; Krings G; Au A; Gray JW; Esserman L
Breast Cancer Res Treat; 2017 Jan; 161(1):17-28. PubMed ID: 27785654
[TBL] [Abstract][Full Text] [Related]
8. Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer.
García-Martínez E; Gil GL; Benito AC; González-Billalabeitia E; Conesa MA; García García T; García-Garre E; Vicente V; Ayala de la Peña F
Breast Cancer Res; 2014 Nov; 16(6):488. PubMed ID: 25432519
[TBL] [Abstract][Full Text] [Related]
9. Immune infiltrates in the breast cancer microenvironment: detection, characterization and clinical implication.
Burugu S; Asleh-Aburaya K; Nielsen TO
Breast Cancer; 2017 Jan; 24(1):3-15. PubMed ID: 27138387
[TBL] [Abstract][Full Text] [Related]
10. Image analysis of immune cell patterns in the human mammary gland during the menstrual cycle refines lymphocytic lobulitis.
Schaadt NS; Alfonso JCL; Schönmeyer R; Grote A; Forestier G; Wemmert C; Krönke N; Stoeckelhuber M; Kreipe HH; Hatzikirou H; Feuerhake F
Breast Cancer Res Treat; 2017 Jul; 164(2):305-315. PubMed ID: 28444535
[TBL] [Abstract][Full Text] [Related]
11. Immune cells are increased in normal breast tissues of BRCA1/2 mutation carriers.
Ogony J; Hoskin TL; Stallings-Mann M; Winham S; Brahmbhatt R; Arshad MA; Kannan N; Peña A; Allers T; Brown A; Sherman ME; Visscher DW; Knutson KL; Radisky DC; Degnim AC
Breast Cancer Res Treat; 2023 Jan; 197(2):277-285. PubMed ID: 36380012
[TBL] [Abstract][Full Text] [Related]
12. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.
Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive evaluation of methods to assess overall and cell-specific immune infiltrates in breast cancer.
Nederlof I; De Bortoli D; Bareche Y; Nguyen B; de Maaker M; Hooijer GKJ; Buisseret L; Kok M; Smid M; Van den Eynden GGGM; Brinkman AB; Hudecek J; Koster J; Sotiriou C; Larsimont D; Martens JWM; van de Vijver MJ; Horlings HM; Salgado R; Biganzoli E; Desmedt C
Breast Cancer Res; 2019 Dec; 21(1):151. PubMed ID: 31878981
[TBL] [Abstract][Full Text] [Related]
14. Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment.
Syed Khaja AS; Toor SM; El Salhat H; Faour I; Ul Haq N; Ali BR; Elkord E
Oncotarget; 2017 May; 8(20):33159-33171. PubMed ID: 28388539
[TBL] [Abstract][Full Text] [Related]
15. Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study.
Cimino-Mathews A; Ye X; Meeker A; Argani P; Emens LA
Hum Pathol; 2013 Oct; 44(10):2055-63. PubMed ID: 23701942
[TBL] [Abstract][Full Text] [Related]
16. CD56+ immune cell infiltration and MICA are decreased in breast lobules with fibrocystic changes.
Kerekes D; Visscher DW; Hoskin TL; Radisky DC; Brahmbhatt RD; Pena A; Frost MH; Arshad M; Stallings-Mann M; Winham SJ; Murphy L; Denison L; Carter JM; Knutson KL; Degnim AC
Breast Cancer Res Treat; 2018 Feb; 167(3):649-658. PubMed ID: 29090365
[TBL] [Abstract][Full Text] [Related]
17. Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumors.
Zhu L; Narloch JL; Onkar S; Joy M; Broadwater G; Luedke C; Hall A; Kim R; Pogue-Geile K; Sammons S; Nayyar N; Chukwueke U; Brastianos PK; Anders CK; Soloff AC; Vignali DAA; Tseng GC; Emens LA; Lucas PC; Blackwell KL; Oesterreich S; Lee AV
J Immunother Cancer; 2019 Oct; 7(1):265. PubMed ID: 31627744
[TBL] [Abstract][Full Text] [Related]
18. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases.
Tabariès S; Ouellet V; Hsu BE; Annis MG; Rose AA; Meunier L; Carmona E; Tam CE; Mes-Masson AM; Siegel PM
Breast Cancer Res; 2015 Mar; 17(1):45. PubMed ID: 25882816
[TBL] [Abstract][Full Text] [Related]
19. Tumor-infiltrating regulatory T cells, CD8/Treg ratio, and cancer stem cells are correlated with lymph node metastasis in patients with early breast cancer.
Solis-Castillo LA; Garcia-Romo GS; Diaz-Rodriguez A; Reyes-Hernandez D; Tellez-Rivera E; Rosales-Garcia VH; Mendez-Cruz AR; Jimenez-Flores JR; Villafana-Vazquez VH; Pedroza-Gonzalez A
Breast Cancer; 2020 Sep; 27(5):837-849. PubMed ID: 32180141
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of S1PR1 and its correlation with immune infiltrates in breast and lung cancers.
Zhong L; Xie L; Yang Z; Li L; Song S; Cao D; Liu Y
BMC Cancer; 2020 Aug; 20(1):766. PubMed ID: 32799825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
